- Home
- LUMO vs DTIL Comparison
LUMO vs DTIL Comparison
Compare LUMO & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUMO
- DTIL
- Stock Information
- Founded
- LUMO 2011
- DTIL 2006
- Country
- LUMO United States
- DTIL United States
- Employees
- LUMO N/A
- DTIL N/A
- Industry
- LUMO Biotechnology: Pharmaceutical Preparations
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- LUMO Health Care
- DTIL Health Care
- Exchange
- LUMO Nasdaq
- DTIL Nasdaq
- Market Cap
- LUMO 37.4M
- DTIL 44.1M
- IPO Year
- LUMO N/A
- DTIL 2019
- Fundamental
- Price
- LUMO $4.34
- DTIL $4.30
- Analyst Decision
- LUMO Buy
- DTIL Strong Buy
- Analyst Count
- LUMO 4
- DTIL 2
- Target Price
- LUMO $9.38
- DTIL $39.50
- AVG Volume (30 Days)
- LUMO 133.0K
- DTIL 113.1K
- Earning Date
- LUMO 11-07-2024
- DTIL 11-04-2024
- Dividend Yield
- LUMO N/A
- DTIL N/A
- EPS Growth
- LUMO N/A
- DTIL N/A
- EPS
- LUMO N/A
- DTIL 1.45
- Revenue
- LUMO $2,205,000.00
- DTIL $75,096,000.00
- Revenue This Year
- LUMO $184.11
- DTIL $50.33
- Revenue Next Year
- LUMO N/A
- DTIL N/A
- P/E Ratio
- LUMO N/A
- DTIL $2.37
- Revenue Growth
- LUMO 26.94
- DTIL 43.62
- 52 Week Low
- LUMO $1.37
- DTIL $4.13
- 52 Week High
- LUMO $4.58
- DTIL $19.43
- Technical
- Relative Strength Index (RSI)
- LUMO 4.26
- DTIL 24.26
- Support Level
- LUMO $4.31
- DTIL $5.12
- Resistance Level
- LUMO $4.39
- DTIL $6.18
- Average True Range (ATR)
- LUMO 0.03
- DTIL 0.46
- MACD
- LUMO -0.44
- DTIL -0.13
- Stochastic Oscillator
- LUMO 0.00
- DTIL 5.21
About LUMO Lumos Pharma Inc.
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.